Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vittorio de Franciscis

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Biochimie|October 1, 2017
Challenging cancer targets for aptamer deliveryVittorio de Franciscis
Journal of Biomedicine & Biotechnology|October 24, 2006
Noncoding RNAs in cancer medicineLaura Cerchia, Vittorio De Franciscis
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Nucleic acid-based aptamers as promising therapeutics in neoplastic diseasesLaura Cerchia, Vittorio de Franciscis
Trends in Biotechnology|August 20, 2010
Targeting cancer cells with nucleic acid aptamersLaura Cerchia, Vittorio de Franciscis
Molecular Therapy. Nucleic Acids|August 22, 2022
Minding the gap: Unlockingthe therapeutic potentialof aptamers and making up for lost timeAnnalisa Di Ruscio, Vittorio de Franciscis
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2015
Developing Aptamers by Cell-Based SELEXSilvia Catuogno, Carla Lucia Esposito, Vittorio de Franciscis
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|November 22, 2014
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cellsCarla Lucia Esposito, Silvia Catuogno, Vittorio de Franciscis
Chemistry & Biology|March 22, 2015
A trojan horse for human immunodeficiency virusSilvia Catuogno, Carla Lucia Esposito, Vittorio de Franciscis
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2015
Aptamer-MiRNA Conjugates for Cancer Cell-Targeted DeliveryCarla L Esposito, Silvia Catuogno, Vittorio de Franciscis
Pharmaceuticals (Basel, Switzerland)|November 10, 2016
Aptamer-Mediated Targeted Delivery of Therapeutics: An UpdateSilvia Catuogno, Carla L Esposito, Vittorio de Franciscis
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Biochimie|October 1, 2017
Challenging cancer targets for aptamer deliveryVittorio de Franciscis
Journal of Biomedicine & Biotechnology|October 24, 2006
Noncoding RNAs in cancer medicineLaura Cerchia, Vittorio De Franciscis
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Nucleic acid-based aptamers as promising therapeutics in neoplastic diseasesLaura Cerchia, Vittorio de Franciscis
Trends in Biotechnology|August 20, 2010
Targeting cancer cells with nucleic acid aptamersLaura Cerchia, Vittorio de Franciscis
Molecular Therapy. Nucleic Acids|August 22, 2022
Minding the gap: Unlockingthe therapeutic potentialof aptamers and making up for lost timeAnnalisa Di Ruscio, Vittorio de Franciscis
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2015
Developing Aptamers by Cell-Based SELEXSilvia Catuogno, Carla Lucia Esposito, Vittorio de Franciscis
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|November 22, 2014
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cellsCarla Lucia Esposito, Silvia Catuogno, Vittorio de Franciscis
Chemistry & Biology|March 22, 2015
A trojan horse for human immunodeficiency virusSilvia Catuogno, Carla Lucia Esposito, Vittorio de Franciscis
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2015
Aptamer-MiRNA Conjugates for Cancer Cell-Targeted DeliveryCarla L Esposito, Silvia Catuogno, Vittorio de Franciscis
Pharmaceuticals (Basel, Switzerland)|November 10, 2016
Aptamer-Mediated Targeted Delivery of Therapeutics: An UpdateSilvia Catuogno, Carla L Esposito, Vittorio de Franciscis
Pageof 7